Iridian Asset Management LLC Precigen, Inc. Transaction History

Iridian Asset Management LLC

$359 Million
Q4 2024

A detailed history of Iridian Asset Management LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Iridian Asset Management LLC holds 5,241,922 shares of PGEN stock, worth $10.6 Million. This represents 1.64% of its overall portfolio holdings.

Number of Shares

5,241,922

Previous 3,775,960 38.82%

Holding current value

$10.6 Million

Previous $3.59 Million 63.65%

% of portfolio

1.64%

Previous 0.8%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	BUY	$0.67 - $1.12 $982,194 - $1.64 Million	1,465,962 Added 38.82%	5,241,922 $5.87 Million
Q3 2024 Oct 25, 2024	BUY	$0.91 - $1.88 $1.55 Million - $3.21 Million	1,706,815 Added 82.49%	3,775,960 $3.59 Million
Q2 2024 Jul 26, 2024	SELL	$1.27 - $1.75 $28,103 - $38,725	-22,129 Reduced 1.06%	2,069,145 $3.27 Million
Q1 2024 May 01, 2024	BUY	$1.21 - $1.75 $104,471 - $151,095	86,340 Added 4.31%	2,091,274 $3.03 Million
Q4 2023 Jan 26, 2024	SELL	$0.89 - $1.41 $65,224 - $103,333	-73,286 Reduced 3.53%	2,004,934 $2.69 Million
Q3 2023 Oct 30, 2023	SELL	$1.08 - $1.85 $1.36 Million - $2.32 Million	-1,255,248 Reduced 37.66%	2,078,220 $2.95 Million
Q2 2023 Aug 09, 2023	SELL	$0.96 - $1.4 $226,366 - $330,117	-235,798 Reduced 6.61%	3,333,468 $3.83 Million
Q1 2023 Apr 28, 2023	BUY	$0.88 - $2.19 $606,895 - $1.51 Million	689,654 Added 23.95%	3,569,266 $3.78 Million
Q4 2022 Jan 31, 2023	SELL	$1.27 - $2.26 $419,470 - $746,459	-330,292 Reduced 10.29%	2,879,612 $4.38 Million
Q3 2022 Nov 07, 2022	SELL	$1.41 - $2.79 $777,214 - $1.54 Million	-551,216 Reduced 14.66%	3,209,904 $6.81 Million
Q2 2022 Jul 29, 2022	BUY	$1.15 - $2.53 $180,233 - $396,514	156,725 Added 4.35%	3,761,120 $5.04 Million
Q1 2022 May 02, 2022	SELL	$1.91 - $3.98 $231,925 - $483,279	-121,427 Reduced 3.26%	3,604,395 $7.61 Million
Q4 2021 Feb 10, 2022	SELL	$3.53 - $5.5 $2.53 Million - $3.95 Million	-717,893 Reduced 16.16%	3,725,822 $13.8 Million
Q3 2021 Nov 10, 2021	SELL	$4.99 - $6.55 $13.2 Million - $17.3 Million	-2,635,700 Reduced 37.23%	4,443,715 $22.2 Million
Q2 2021 Aug 11, 2021	SELL	$6.24 - $8.22 $1.7 Million - $2.24 Million	-272,503 Reduced 3.71%	7,079,415 $46.2 Million
Q1 2021 May 11, 2021	BUY	$6.74 - $10.95 $46.8 Million - $76 Million	6,943,452 Added 1699.88%	7,351,918 $50.7 Million
Q4 2020 Feb 08, 2021	BUY	$3.75 - $10.56 $180,000 - $506,880	48,000 Added 13.32%	408,466 $4.17 Million
Q3 2020 Nov 02, 2020	BUY	$3.5 - $6.2 $116,770 - $206,850	33,363 Added 10.2%	360,466 $1.26 Million
Q1 2020 May 11, 2020	BUY	$1.46 - $7.19 $477,570 - $2.35 Million	327,103 New	327,103 $1.11 Million

Others Institutions Holding PGEN

# of Institutions

144

Shares Held

160M

Call Options Held

136K

Put Options Held

4.8K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $420M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Iridian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iridian Asset Management LLC with notifications on news.

Account

Iridian Asset Management LLC Precigen, Inc. Transaction History